scholarly article | Q13442814 |
P50 | author | Michael Weller | Q2779469 |
Guido Reifenberger | Q30004009 | ||
P2093 | author name string | Gunter Meister | |
Patrick Roth | |||
Kerstin Kaulich | |||
Paula Codó | |||
Manuela Silginer | |||
Daniel Schraivogel | |||
P2860 | cites work | Similar sequence-free amplification of human glyceraldehyde-3-phosphate dehydrogenase for real time RT-PCR applications | Q46410633 |
Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome | Q48573837 | ||
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice | Q58807888 | ||
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease | Q61927871 | ||
Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system | Q73784537 | ||
MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts | Q82414820 | ||
The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores | Q83056445 | ||
GDF15 Is Related to Anemia and Hepcidin in Kidney Allograft Recipients | Q86998827 | ||
TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 | ||
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored | Q24607390 | ||
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators | Q28276193 | ||
The roles of TGFβ in the tumour microenvironment | Q33630845 | ||
Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer | Q34099900 | ||
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape | Q34365811 | ||
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy | Q34394233 | ||
TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility | Q34713446 | ||
Glioma cancer stem cells induce immunosuppressive macrophages/microglia | Q34992518 | ||
Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response | Q35043529 | ||
DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines | Q35098017 | ||
Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. | Q35963587 | ||
Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins | Q36324236 | ||
microRNAs associated with the different human Argonaute proteins | Q36341483 | ||
Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1 | Q36746688 | ||
Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A | Q36981029 | ||
Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas | Q37435455 | ||
Regulation of cell signalling by uPAR. | Q37660895 | ||
Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta | Q38331875 | ||
Immunotherapy for glioblastoma: concepts and challenges | Q38592188 | ||
Integrin control of the transforming growth factor-β pathway in glioblastoma. | Q39200138 | ||
GDF-15 contributes to proliferation and immune escape of malignant gliomas | Q39695192 | ||
Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells | Q39805059 | ||
Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. | Q39956664 | ||
A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance | Q40596797 | ||
Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. | Q40722521 | ||
The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. | Q40749068 | ||
TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. | Q42399810 | ||
LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase. | Q42484553 | ||
Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. | Q43945272 | ||
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. | Q44200074 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell migration | Q189092 |
neoplastic invasiveness | Q112498967 | ||
P304 | page(s) | 7732-7746 | |
P577 | publication date | 2016-01-04 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Control of glioma cell migration and invasiveness by GDF-15 | |
P478 | volume | 7 |
Q58701186 | A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway |
Q40213573 | Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma |
Q38828969 | Biological activity of tumor-treating fields in preclinical glioma models |
Q92894347 | Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping |
Q47874491 | Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma initiating cells. |
Q92619249 | Coordinated Expression of Ras Suppressor 1 (RSU-1) and Growth Differentiation Factor 15 (GDF15) Affects Glioma Cell Invasion |
Q52316138 | Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines. |
Q64083844 | Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma |
Q60920838 | Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15) |
Q64991376 | Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues. |
Q96127081 | Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments |
Q90706550 | Mechanical Compression Regulates Brain Cancer Cell Migration Through MEK1/Erk1 Pathway Activation and GDF15 Expression |
Q52691329 | New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection |
Q92156666 | Visfatin Mediates Malignant Behaviors through Adipose-Derived Stem Cells Intermediary in Breast Cancer |
Search more.